Innovision Limited has completed its quarterly regulatory filing by submitting the mandatory compliance certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026. The submission was made to both BSE Limited and National Stock Exchange of India Limited on April 15, 2026.

Regulatory Compliance Details

The certificate was issued under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, which mandates listed companies to report details of securities dematerialized during each quarter. Ms. Jyoti Sachdeva, Company Secretary and Compliance Officer, signed the submission on behalf of Innovision Limited.

Share Transfer Activity

KFin Technologies Limited, serving as the company's Registrar and Share Transfer Agent, certified that all required details have been furnished to the stock exchanges where Innovision's shares are listed. The certificate specifically confirms that during Q4 FY26, there were no requests for dematerialization or rematerialization of shares.

Compliance Framework

The submission fulfills Innovision's obligations under SEBI's regulatory framework for depositories and participants. The certificate was also copied to National Securities Depository Limited and Central Depository Services (India) Limited, ensuring comprehensive regulatory compliance across all relevant depositories.

This routine compliance filing reflects Innovision's commitment to maintaining transparency and adhering to regulatory requirements as a publicly listed company on both BSE and NSE.

Innovision Limited announced its unaudited financial results for Q3FY26 ended December 31, 2025, following a board meeting held on April 13, 2026. The company delivered strong performance across key financial metrics, demonstrating significant growth in profitability and operational efficiency.

Financial Performance Highlights

The company reported consolidated revenue of ₹2.33 billion for Q3FY26 compared to ₹2.28 billion in the corresponding quarter of the previous year. Net profit showed remarkable improvement, rising 42% to ₹44 million from ₹31 million year-on-year.

EBITDA and Margin Expansion

The standout performance came from EBITDA growth, which increased 43% to ₹107 million from ₹75 million in Q3FY25. EBITDA margin expanded significantly to 4.60% compared to 3.30% in the previous year, representing an improvement of 130 basis points. This margin expansion reflects enhanced operational efficiency and better cost management.

Nine-Month Performance

For the nine months ended December 31, 2025, consolidated revenue reached ₹7.13 billion compared to ₹6.41 billion in the corresponding period of the previous year. Net profit for the nine-month period stood at ₹245 million versus ₹182 million in the previous year, showing consistent growth momentum.

Regulatory Compliance and Disclosure

The financial results were approved in compliance with Regulation 33 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The company submitted newspaper advertisements pursuant to Regulation 47 of SEBI regulations, with publications in Financial Express (English) and Jansatta (vernacular language) on April 14, 2026.

Corporate Developments

The board meeting also addressed subsequent events, including the resignation of Ms. Sudha Hooda as Independent Director effective April 6, 2026, and the appointment of Mr. Aditya Jha as Independent Director effective April 10, 2026, subject to shareholder approval. The company's shares are listed on NSE and BSE following a successful IPO completed in March 2026.